FDA Reports Concerns Over Blood Clot-Causing Birth Control

Posted on

The Food and Drug Administration is concerned about certain birth control pills increasing the patient’s risk of blood clots, according to recent news sources.

The birth control pills being observed contain the hormone drospirenone and include:

  • Safyral
  • Syeda
  • Ocella
  • Yasmin
  • Zarah
  • Beyaz
  • Gianvi
  • Loryna
  • Yaz
  • Drospirenone and ethinyl estradiol

A review by the FDA of two studies conducted in 2011 found that those using pills containing the hormone were two to three times more at risk of venous thromboembolism events (VTE) than women who used a pill containing the hormone levonorgestrel.

VTE is a condition in which a blood clot forms within a vein, typically the thigh or lower leg. It can potentially block and artery, causing pulmonary embolism, which can be life-threatening.

The FDA is continuing to review studies of the hormones.

As a Los Angeles personal injury lawyer, I hope that you discuss any medical conditions you experience as a result of taking this medication with your healthcare provider. If you are experiencing atypical symptoms, please contact your doctor right away. In my experience as a product liability lawyer, I know that drugs can sometimes have unexpected side effects. If you or someone you love has been injured by a drug, I advise you to contact a personal injury lawyer as soon as possible to discuss your legal options.